Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?

Arthritis & Rheumatism

Volumn 30, Issue 12, 1987, Pages 1435-1436

  Wallace, Daniel J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; FEMALE; HUMAN; LETTER; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM;

ADULT; FEMALE; HUMAN; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; THROMBOEMBOLISM;

EID: 0023515407     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780301219     Document Type: Letter

References (11)

1. Anti‐phospholipid antibodies
2. The 1982 revised criteria for the classification of systemic lupus erythematosus
3. Clinical and laboratory manifestations of systemic lupus erythematosus
4. Evidence that antimalarial drugs act as phospholipid analog inhibitors of key pathways of phospholipid metabolism in leucocytes
5. Prevention of postoperative deep vein thrombosis in legs by orally administered hydroxychloroquine sulphate
6. Prevention of venous thromboembolism by administration of hydroxychloroquine: a preliminary report
7. Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulphate after total hip replacement
8. Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty
9. Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin
10. Hydroxychloroquine sulfate prophylaxis for pulmonary embolism for patients with low friction arthroplasty
11. Desludging action of hydroxychloroquine in rheumatoid arthritis